Science Explorer Interactive view Map
Company · Lianyun · China

Hansoh Pharma (China)

hansoh.cnROR OpenAlex
Research works
57
▼ 52% vs 2013–17
Citations
261
4.6 per fractional work
Top-10% rate
8.3%
record average 16.5%
Open access
33%
world 28%

Not ranked overall: Hansoh Pharma (China) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.18× its world share, 0 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 3.75× its world share, 4 worksBiochemistry, Geneti…Immunology and Microbiology: 1.02× its world share, 0 worksImmunology and Micro…Neuroscience: 0.31× its world share, 0 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 15.01× its world share, 1 worksPharmacology, Toxico…Chemistry: 8.98× its world share, 3 worksChemistryEnergy: 0.27× its world share, 0 worksEnergyEngineering: 0.25× its world share, 1 worksEngineeringEnvironmental Science: 0.27× its world share, 0 worksEnvironmental ScienceMaterials Science: 0.17× its world share, 0 worksMaterials ScienceMathematics: 1.50× its world share, 0 worksMathematicsDentistry: 1.21× its world share, 0 worksDentistryHealth Professions: 0.17× its world share, 0 worksHealth ProfessionsMedicine: 2.53× its world share, 9 worksMedicineEconomics, Econometrics and Finance: 0.41× its world share, 0 worksEconomics, Econometr…Psychology: 0.04× its world share, 0 worksPsychology1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Pharmacology, Toxicology and Pharmaceutics, 15.0×. Every wedge is a field page.

Which keywords describe research at Hansoh Pharma (China)?

By fractional works in all years, weighted toward what it does more of than the world: Chemotherapy, Targeted Therapy, Clinical Trials, Method Validation, Synthesis, Green Analytical Chemistry, Pharmaceutical Analysis and Medicinal Chemistry.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Chemotherapy5▲ 13×11 topics
  2. Targeted Therapy4▲ 30×3 topics
  3. Clinical Trials4▲ 10×6 topics
  4. Cancer3▲ 4.1×14 topics
  5. Inflammation3▲ 2.4×10 topics
  6. Method Validation3▲ 72×2 topics
  7. Cardiovascular Disease3▲ 4.8×10 topics
  8. Synthesis3▲ 9.0×6 topics
  9. Green Analytical Chemistry3▲ 54×1 topic
  10. Pharmaceutical Analysis3▲ 160×1 topic
  11. Medicinal Chemistry3▲ 12×6 topics
  12. ALK Inhibitors2▲ 75×1 topic
  13. EGFR Mutations2▲ 75×1 topic
  14. Genomic Profiling2▲ 43×2 topics
  15. Herbal Medicine2▲ 18×2 topics
  16. Liquid Chromatography2▲ 28×2 topics
  17. Chiral Separation2▲ 30×1 topic
  18. Gas Chromatography2▲ 30×1 topic
  19. Heterocyclic Compounds2▲ 23×3 topics
  20. Heart Failure2▲ 7.7×3 topics
  21. Anticancer Agents2▲ 13×3 topics
  22. Monoclonal Antibody2▲ 48×2 topics
  23. Phytochemistry2▲ 26×4 topics
  24. Drug Discovery2▲ 7.7×6 topics
  25. Angiogenesis2▲ 7.2×5 topics
  26. Glycosylation2▲ 13×3 topics
  27. Traditional Chinese Medicine2▲ 18×2 topics
  28. Chronic Kidney Disease2▲ 11×5 topics
  29. Mutation2▲ 18×2 topics
  30. Resistance2▲ 24×2 topics
  31. Tumor Microenvironment2▲ 7.7×6 topics
  32. BCR-ABL2▲ 94×1 topic
  33. Imatinib2▲ 94×1 topic
  34. Prognostic Factors2▲ 5.8×4 topics
  35. Bioactive Compounds1▲ 13×5 topics
  36. Biological Evaluation1▲ 19×3 topics
  37. Pharmacology1▲ 7.4×5 topics
  38. Precision Medicine1▲ 7.7×4 topics
  39. Pharmacological Effects1▲ 29×1 topic
  40. Quality Control1▲ 20×1 topic

Which research topics does Hansoh Pharma (China) publish most on?

By volume in 2022–2025: Lung Cancer Treatments and Mutations, Viral Infectious Diseases and Gene Expression in Insects, Protein purification and stability and Drug Solubulity and Delivery Systems.

Lung Cancer Treatments a…2Lung Cancer Treatments and Mutations: 2 fractional worksViral Infectious Disease…1Viral Infectious Diseases and Gene Expression in Insects: 1 fractional worksProtein purification and…1Protein purification and stability: 1 fractional worksDrug Solubulity and Delivery Systems: 1 fractional worksLung Cancer Diagnosis and Treatment: 1 fractional worksProtein Degradation and Inhibitors: 0 fractional worksDiabetes Treatment and Management: 0 fractional worksChronic Myeloid Leukemia Treatments: 0 fractional worksCancer Genomics and Diagnostics: 0 fractional worksGranular flow and fluidized beds: 0 fractional works
Pulmonary and Respiratory MedicineMolecular BiologyPharmaceutical ScienceEndocrinology, Diabetes and Metabolism3 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Lung Cancer Treatments and Mutations Pulmonary and Respiratory Medicine 2 works
  2. 2 Viral Infectious Diseases and Gene Expression in Insects Molecular Biology 1 works
  3. 3 Protein purification and stability Molecular Biology 1 works
  4. 4 Drug Solubulity and Delivery Systems Pharmaceutical Science 1 works
  5. 5 Lung Cancer Diagnosis and Treatment Pulmonary and Respiratory Medicine 1 works
  6. 6 Protein Degradation and Inhibitors Molecular Biology 0 works
  7. 7 Diabetes Treatment and Management Endocrinology, Diabetes and Metabolism 0 works
  8. 8 Chronic Myeloid Leukemia Treatments Hematology 0 works
  9. 9 Cancer Genomics and Diagnostics Cancer Research 0 works
  10. 10 Granular flow and fluidized beds Computational Mechanics 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available33.1%not open66.9%

World: 28% of research is openly available.

with international co-authors11.6%domestic only88.4%

World: 19% is written across borders.

How has Hansoh Pharma (China)'s research output changed?

Output in 2018–2022 was 52% lower than in 2013–2017.

201020152020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Lianyun

All research institutions in Lianyun

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.